SEC Form 4 · accession 0001144204-15-000863
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Keith
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase shares of Common StockF1,F2 | $0.34 | Jan 2, 2015 | A | 45,000 | A | — | Jan 2, 2025 | Common Stock | 45,000 | 285,000 | D |
Explanation of responses
- F1Represents annual independent Board member compensation pursuant to the 2013 Equity Incentive Plan. The options vest monthly in 1/12 increments throughout 2015.
- F2Independent director compensation approved by the Board of Directors.